Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA Study Says Merck's Gardasil Is Safe, Vexing Media and Activists
- FDA Study Says Merck's Gardasil Is Safe, Vexing Media and ActivistsRE: FDA Study Says Merck's Gardasil Is Safe, Vexing Media and ActivistsAnd what do you say to Dr. Diane Harper? Is merck not also responsible for Vioxx? After the vioxx and paxil scandals who in the name of god...
- Discussion threads 2008-10-23
Additional Resources
- Study Says Merck's Gardasil Is Safe, Vexing Media and Activists
- The CDC studied 370,000 doses of Merck's Gardasil vaccine for HPV and cervical cancer, and found that the drug is not linked to the risks that the media and conservative activists say it is. The news will come as a frustration to the growing body of Americans who believe that...
- Blog posts 2008-10-23
- FDA to New Drugs: It's Hammer Time
- Wonder no further whether the recent litany of drug-safety problems would make the Food and Drug Administration more cautious about approving new drugs. In just the past four days, the agency has thrown some serious sand into the industry's drug-development works, delaying or derailing three separate programs of widely varying...
- Blog posts 2008-04-29
- BMJ: PDUFA, Speedy Marketing Spread Risks of New Drugs
- The faster a drug is approved the more likely it is to be withdrawn or have safety warnings added later, according to the author of a study in the British Medical Journal. In addition, the rapid rollout of mass marketing plans increases the risk that large numbers of patients will...
- Blog posts 2008-12-08
- Bellwether Fosomax trial starts today
- In drug liability litigation, the first case to come to trial always is closely watched. Lawyers, plaintiffs and companies alike want to know their opponents' strategies. And perhaps most importantly, they want to know how jurors respond to testimony. The inaugural trial in Merck's defense of its Fosamax bone drug...
- News items 2009-08-10
- Is Merck's Gardasil Linked To Lou Gehrig's Disease?
- Merck's Gardasil made big news late last week - and it wasn't all good. First, the FDA endorsed the vaccine to thwart genital warts in boys and young men. This is a mild plus for the drugmaker; Gardasil is already approved to ward off the human papillomavirus, or HPV, in...
- News items 2009-10-22
- FDA: 'Premature' to draw Vioxx conclusions
- The FDA Office of Drug Evaluation V Director Robert Delap says it is "premature" to draw conclusions from recent clinical data on Merck's arthritis drug Vioxx rofecoxib, which showed that patients taking the drug suffered significantly more heart attacks than occurred in patients taking the NSAID naproxen. The data came...
- Research articles 2000-06-01
- NEJM: Foreign Drug Trials Could Hurt U.S. Patients
- The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...
- Blog posts 2009-02-19
- Gilead Q3 2006 Earnings Call Transcript
- Question-and-Answer SessionOperator [Operator Instructions]. Our first question is from the line of Meg Malloy, with Goldman Sachs. Meg Malloy - Goldman Sachs Thanks very much. Two quick questions. First, for Norbert -- could you clarify a little bit -- I am not clear on the Integrase...
- Earnings calls 2006-10-18
- << Previous
- page 1 of 1
- Next >>
